You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
A meta-analysis of 29 studies, none longer than six months, has shown that incretin therapies (like Byetta and Januvia) are moderately effective in lowering blood glucose in people with type 2 diabetes, especially after meals.
Better yet, they do so without the weight gain associated with many type 2 medications.
Incretin therapy uses drugs that increase the action of GLP-1, a hormone secreted by the intestine that lowers blood glucose. Studies of two types of incretin therapy were assessed: A GLP-1 analogue, exenatide (Byetta), which is an injectable synthetic copy of GLP-1 that lasts much longer in the body than natural GLP-1; and DPP-4 inhibitors, like sitagliptin (Januvia), which are pills that block the breakdown of natural GLP-1, again making it last longer in the body.
The results of the meta-analysis indicate that incretin therapy appears to be safe, at least over the short run, with minimal negative side effects. For people who still have adequate beta cells, are at risk for hypoglycemia, and need to lose weight, it appears to be a good alternative. However, it needs lengthier evaluation to assess its long-term safety and effectiveness.
Journal of the American Medical Association, July 2007
EurekAlert
Categories: Blood Glucose, Blood Sugar, Diabetes, Diabetes, Losing weight, Low Blood Sugar, Type 2 Issues, Type 2 Medications
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...